Undoubtably, dysregulation of these peptide systems contributes to overweight, disproportion in body composition, obesity and eating disorders
Within the findings were several considerations for patients and payers: High costs for GLP-1 medications ranked as respondents top concern (followed by lack of control over who is prescribed the medications) 93% covered GLP-1s for management of diabetes in the previous plan year
KFF estimates 3.8 million Medicare beneficiaries will meet the coverage eligibility requirements
The researchers also found that the mean weight loss between groups was significantly different, with those who had BMS having a 31.1 percent weight reduction and those taking GLP-1s having only a 12.9 percent reduction
She also writes about plastic surgery, racial disparities in healthcare, and breaking health news
These medications are designed to be paired with diet and exercise to achieve significant and sustainable weight loss